Erik Stancofski, MD
Payments from drug & device makers
What this record shows
This record is dominated by education: $14,000 of the $19,149 with a category attached, or 73.1%. Intuitive Surgical accounts for 89.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $10,415 and has fallen 95.4% since, to $476 in 2025. Among surgery clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $217.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$17K
- Boston Scientific$353
- Johnson & Johnson$311
- Davol Inc.$303
- BD$245
- Medtronic$231
- plus $667 from 13 others
What the payments were for
- Travel & lodging$2,30512%
- Food & beverage$2,83015%
- Education$14,00073%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 32 | $17,038 |
| Boston Scientific | 3 | $353 |
| Johnson & Johnson | 20 | $311 |
| Davol Inc. | 4 | $303 |
| BD | 3 | $245 |
| Medtronic | 3 | $231 |
| W. L. Gore & Associates, Inc. | 3 | $182 |
| TELA Bio, Inc. | 5 | $113 |
| KCI USA, Inc. | 1 | $82 |
| Innocoll Pharmaceuticals Limited | 3 | $77 |
| Angiodynamics, Inc. | 2 | $42 |
| Smith+Nephew | 2 | $35 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| AstraZeneca | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Lemaitre Vascular, Inc. | 1 | $20 |
| AbbVie | 1 | $16 |
| Covidien LP | 1 | $16 |
| Conmed Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,149 in reported general payments places this provider in the 95th percentile of 89 surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 24 | $131 |
| Metronidazole | 25 | $69 |
| Oxycodone Hcl | 12 | $39 |
| Metoclopramide Hcl | 24 | $35 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other surgery in Lewes
- Mark FaccioloLewes$17K
- Ramakrishna TatineniLewes$7K
- John TysonLewes$6K
- Clara HigginsLewes$994
- David NehringLewes$677
- Peter SantoroWilmington$166K
- Karen BarbosaRehoboth Beach$60K
- Lydell LettsomeDover$32K
- M Lisa AtteberyRehoboth Beach$22K
- Veronica Bustillo-ArucaNewark$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.